Zola revenues surge 24% in Q3 2026 amid new espresso product launch
Arcadia Biosciences reported record third-quarter 2026 revenue for its Zola brand, driven by strong summer programs and a new espresso formulation. Gross margins improved year-over-year due to a tariff refund.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed